临床重症患者中的雷宁
Yuki Kotani1, Mark Chappell2, Giovanni Landoni3,4
1Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.
Annals of intensive care
|May 22, 2024
概括
危急病患者蛋白水平升高可能表明疾病严重程度并预测不良结果,在死亡率预测方面表现优于乳酸. 列宁作为指导动脉素II治疗在休克复苏中的生物标志物具有前景.
科学领域:
- 关键护理医学 关键护理医学
- 脏生理学 脏生理学
- 血液动力学调节 血液动力学调节
背景情况:
- 氨酸-血管素系统 (RAS) 对于恒温至关重要,但其在危急性病的低血压患者中的作用尚未得到充分研究.
- 对抗冲击治疗的 ангиотензин II (Ang II) 批准增加了对重症监护中的RAS的兴趣.
- 系统的发起者 - - 列宁 - - 在应对低血压时释放出来,这可能反映了疾病的严重程度.
研究的目的:
- 审查当前对雷宁作为重症患者生物标志物的理解.
- 探索雷宁在复苏中临床应用的未来方向.
- 讨论雷宁的预后准确性和引导Ang II治疗的潜力.
主要方法:
- 这篇叙述性综述综合了现有的关于严重病患者群体内雷宁的文献.
- 它检查了关于素的预后价值及其与治疗反应的关联的研究.
- 该审查考虑了雷宁试验开发的局限性和未来需求.
主要成果:
- 蛋白水平升高与疾病严重程度相关,并预测重症患者的治疗结果不佳.
- 与乳酸相比,伦宁在死亡率预测方面显示出更高的预后准确性.
- 雷宁降低可以评估Ang II治疗的有效性,并可以确定受益于Ang II的患者.
结论:
- 列宁是一种有前途的生物标志物,用于预后和指导治疗危急性低血压患者.
- 需要进一步的前性研究来证实雷宁的功效.
- 开发快速的,点的护理雷宁测试对于临床整合至关重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:25Antihypertensive Drugs: Direct Renin Inhibitors
597
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
597
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:11Renal Failure: Dose Adjustments
84
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
84
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363